Low dose interleukin-2 selectively expands circulating regulatory T cells but fails to promote liver allograft tolerance in humans
Top Cited Papers
Open Access
- 7 September 2022
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 78 (1) , 153-164
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Origin and Biology of the Allogeneic ResponseCold Spring Harbor Perspectives in Medicine, 2013
- Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipientsHepatology, 2013
- Regulatory T-cell therapy for transplantationCurrent Opinion in Organ Transplantation, 2012
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host DiseaseNew England Journal of Medicine, 2011
- Response to self antigen imprints regulatory memory in tissuesNature, 2011
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsJournal of Experimental Medicine, 2010
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN-γ and CXCR3 LigandsCancer Research, 2008
- New Insights into Mechanisms of Spontaneous Liver Transplant Tolerance: The Role of Foxp3-Expressing CD25+CD4+ Regulatory T CellsAmerican Journal of Transplantation, 2008
- Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4+CD25+ regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantationSurgery, 2007
- Targeted in vivo expression of IFN-γ-inducible protein 10 induces specific antitumor activityJournal of Leukocyte Biology, 2006